毒品战争
Drug wars
Robin Feldman · 初版 2017 年
4人推荐
4位读者提及
4次提及
“尽管处方药价格高昂的丑闻持续占据各大新闻头条，但制药公司用以阻击仿制药竞争的手段却鲜为人知，甚至连负责对其进行监管的立法者也知之甚少。在这部开创性的著作中，Robin Feldman与Evan Frondorf揭示了医药市场的内部运作机制，展现了制药公司如何操弄卫生政策以实现违背公众利益的目标。通过极其生动的笔调，他们列举了仿制药竞争如何长年遭受打压的具体案例，导致医疗费用暴涨至
Hacker News 上怎么说
正在加载完整评论……
想了解仿制药审批那些错综复杂、拜占庭式的流程，有一期非常精彩的讨论，我推荐最近的一期 EconTalk[0]。嘉宾写了一本书叫《Drug Wars: How Big Pharma Raises Prices and Keeps Generics off the Market》[1]。当牵扯到高达数亿美元的营收时，那些大药企有极大的动力去拖延或阻挠仿制药上市……
For a fantastic discussion about the Byzantine process for generic drug approval, I recommend a recent episode of EconTalk[0]. The guest wrote a book called "Drug Wars: How Big Pharma Raises Prices and Keeps Generics off the Market"[1]. When up to half a billion dollars of revenue is at stake, the drug companies have incredible incentives to delay or prevent generics…
我建议任何对降低药价感兴趣的人都去听听 Robin Feldman 上的这期 EconTalk[0]。他们在节目里讨论了她的书《Drug Wars how big pharma raises prices and keeps generics off the market》[1]。在节目中他们聊了制药公司搞的各种猫腻手段。如果你想要真正的改革，就必须关注……
I would suggest anyone who is interested in reducing drug prices listen to this econtalk episode with Robin Feldman[0]. They discuss her book "Drug Wars how big pharma raises prices and keeps generics off the market"[1] In the episode they discuss all sorts of shenanigans that pharmaceutical companies pull. If you want real reform you need to look at…
econlog 播客[1]关于《Drug Wars》[2]这本书的那期节目很好地剖析了其中的一些荒唐乱象。《纽约时报》总想把所有责任甩给保险公司，但保险公司其实是在设法省钱。仿制药系统完全是一套卡夫卡式的监管和审批流程。[1] http://www.econtalk.org/archives/2017/06/robin_feldman_o.htm...…
Some of this insanity is covered nicely in the econlog podcast[1] on the book Drug Wars[2]. The NY Times always wants to throw all of the blame at insurers, but they are trying to save money. The generic system is a Kafakaesque set of regulations and processes. [1] http://www.econtalk.org/archives/2017/06/robin_feldman_o.htm...…
制药业通常被拿来当作必须有专利保护的典型范例；然而，事实远非表面那么显然。可以去看看 Robin Feldman 的书《Drug Wars》（这里有一篇关于此书对她的采访：http//www.econtalk.org/robin-feldman-on-drug-patents-generics-and-drug-wars/）
The pharmaceutical industry is usually given as the prime example of an industry where patent protection is necessary; however, this is far from obvious. See Robin Feldman's book Drug Wars (there is an interview with her about it here: http//www.econtalk.org/robin-feldman-on-drug-patents-generics-and-drug-wars/)